EpCAM Controls Actomyosin Contractility and Cell Adhesion by Direct Inhibition of PKC

Developmental Cell

Volumn 27, Issue 3, 2013, Pages 263-277

  Maghzal, Nadim ^a   Kayali, Hulya A ^a,b   Rohani, Nazanin ^a   Kajava, Andrey V ^c   Fagotto, François ^a  

^a MCGILL UNIVERSITY   (Canada)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

^c Centre National de la Recherche Scientifique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; EPITHELIAL CELL ADHESION MOLECULE; MYOSIN ADENOSINE TRIPHOSPHATASE; PROTEIN KINASE C;

AMPHIBIA; APOPTOSIS; ARTICLE; CANCER CELL; CELL ADHESION; CELL DEATH; CONFORMATIONAL TRANSITION; DNA CLEAVAGE; EMBRYONAL TISSUE; ENDOCYTOSIS; HUMAN; INTRACELLULAR SIGNALING; MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ACTOMYOSIN; ANIMALS; ANTIGENS, NEOPLASM; CELL ADHESION; CELL ADHESION MOLECULES; CELLS, CULTURED; COLONIC NEOPLASMS; EMBRYO, NONMAMMALIAN; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MUSCLE CONTRACTION; PEPTIDE FRAGMENTS; PROTEIN KINASE C; XENOPUS LAEVIS;

EID: 84887615793     PISSN: 15345807     EISSN: 18781551     Source Type: Journal    
DOI: 10.1016/j.devcel.2013.10.003     Document Type: Article

References (42)

1. Ammons W.S., Bauer R.J., Horwitz A.H., Chen Z.J., Bautista E., Ruan H.H., Abramova M., Scott K.R., Dedrick R.L. Invitro and invivo pharmacology and pharmacokinetics of a human engineered monoclonal antibody to epithelial cell adhesion molecule. Neoplasia 2003, 5:146-154.
2. Chen C.L., Chen H.C. Functional suppression of E-cadherin by protein kinase Cdelta. J.Cell Sci. 2009, 122:513-523.
3. Cubas R., Li M., Chen C., Yao Q. Trop2: a possible therapeutic target for late stage epithelial carcinomas. Biochim. Biophys. Acta 2009, 1796:309-314.
4. Denzel S., Maetzel D., Mack B., Eggert C., Bärr G., Gires O. Initial activation of EpCAM cleavage via cell-to-cell contact. BMC Cancer 2009, 9:402.
5. Gaiser M.R., Lämmermann T., Feng X., Igyarto B.Z., Kaplan D.H., Tessarollo L., Germain R.N., Udey M.C. Cancer-associated epithelial cell adhesion molecule (EpCAM; CD326) enables epidermal Langerhans cell motility and migration invivo. Proc. Natl. Acad. Sci. USA 2012, 109:E889-E897.
6. Gostner J.M., Fong D., Wrulich O.A., Lehne F., Zitt M., Hermann M., Krobitsch S., Martowicz A., Gastl G., Spizzo G. Effects ofEpCAM overexpression on human breast cancer cell lines. BMC Cancer 2011, 11:45.
7. Halloran M.C., Wolman M.A. Repulsion or adhesion: receptors make the call. Curr. Opin. Cell Biol. 2006, 18:533-540.
8. Huang C., Jacobson K., Schaller M.D. MAP kinases and cell migration. J.Cell Sci. 2004, 117:4619-4628.
9. Iwabu A., Smith K., Allen F.D., Lauffenburger D.A., Wells A. Epidermal growth factor induces fibroblast contractility and motility via a protein kinase C delta-dependent pathway. J.Biol. Chem. 2004, 279:14551-14560.
10. Jaggi M., Rao P.S., Smith D.J., Wheelock M.J., Johnson K.R., Hemstreet G.P., Balaji K.C. E-cadherin phosphorylation by protein kinase D1/protein kinase Cmu is associated with altered cellular aggregation and motility in prostate cancer. Cancer Res. 2005, 65:483-492.
11. Kennelly P.J., Krebs E.G. Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases. J.Biol. Chem. 1991, 266:15555-15558.
12. Kinoshita N., Iioka H., Miyakoshi A., Ueno N. PKC delta is essential for Dishevelled function in a noncanonical Wnt pathway that regulates Xenopus convergent extension movements. Genes Dev. 2003, 17:1663-1676.
13. Kishimoto A., Nishiyama K., Nakanishi H., Uratsuji Y., Nomura H., Takeyama Y., Nishizuka Y. Studies on the phosphorylation of myelin basic protein by protein kinase C and adenosine 3':5'-monophosphate-dependent protein kinase. J.Biol. Chem. 1985, 260:12492-12499.
14. Le T.L., Joseph S.R., Yap A.S., Stow J.L. Protein kinase C regulates endocytosis and recycling of E-cadherin. Am. J. Physiol. Cell Physiol. 2002, 283:C489-C499.
15. Lecuit T. "Developmental mechanics": cellular patterns controlled by adhesion, cortical tension and cell division. HFSP J 2008, 2:72-78.
16. Lei Z., Maeda T., Tamura A., Nakamura T., Yamazaki Y., Shiratori H., Yashiro K., Tsukita S., Hamada H. EpCAM contributes to formation of functional tight junction in the intestinal epithelium by recruiting claudin proteins. Dev. Biol. 2012, 371:136-145.
17. Litvinov S.V., Velders M.P., Bakker H.A., Fleuren G.J., Warnaar S.O. Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule. J.Cell Biol. 1994, 125:437-446.
18. Maaser K., Borlak J. A genome-wide expression analysis identifies a network of EpCAM-induced cell cycle regulators. Br. J. Cancer 2008, 99:1635-1643.
19. Maetzel D., Denzel S., Mack B., Canis M., Went P., Benk M., Kieu C., Papior P., Baeuerle P.A., Munz M., Gires O. Nuclear signalling by tumour-associated antigen EpCAM. Nat. Cell Biol. 2009, 11:162-171.
20. Maghzal N., Vogt E., Reintsch W., Fraser J.S., Fagotto F. The tumor-associated EpCAM regulates morphogenetic movements through intracellular signaling. J.Cell Biol. 2010, 191:645-659.
21. Marais R.M., Nguyen O., Woodgett J.R., Parker P.J. Studies on the primary sequence requirements for PKC-alpha, -beta 1 and -gamma peptide substrates. FEBS Lett. 1990, 277:151-155.
22. Münz M., Kieu C., Mack B., Schmitt B., Zeidler R., Gires O. The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene 2004, 23:5748-5758.
23. Munz M., Baeuerle P.A., Gires O. The emerging role of EpCAM in cancer and stem cell signaling. Cancer Res. 2009, 69:5627-5629.
24. Nagao K., Zhu J., Heneghan M.B., Hanson J.C., Morasso M.I., Tessarollo L., Mackem S., Udey M.C. Abnormal placental development and early embryonic lethality in EpCAM-null mice. PLoS ONE 2009, 4:e8543.
25. Newton A.C. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem. Rev. 2001, 101:2353-2364.
26. Nguyen D.H., Catling A.D., Webb D.J., Sankovic M., Walker L.A., Somlyo A.V., Weber M.J., Gonias S.L. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner. J.Cell Biol. 1999, 146:149-164.
27. Nishikawa K., Toker A., Johannes F.J., Songyang Z., Cantley L.C. Determination of the specific substrate sequence motifs of protein kinase C isozymes. J.Biol. Chem. 1997, 272:952-960.
28. Noren N.K., Pasquale E.B. Eph receptor-ephrin bidirectional signals that target Ras and Rho proteins. Cell. Signal. 2004, 16:655-666.
29. Osta W.A., Chen Y., Mikhitarian K., Mitas M., Salem M., Hannun Y.A., Cole D.J., Gillanders W.E. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res. 2004, 64:5818-5824.
30. Patriarca C., Macchi R.M., Marschner A.K., Mellstedt H. Epithelial cell adhesion molecule expression (CD326) in cancer: a short review. Cancer Treat. Rev. 2012, 38:68-75.
31. Rosse C., Linch M., Kermorgant S., Cameron A.J., Boeckeler K., Parker P.J. PKC and the control of localized signal dynamics. Nat. Rev. Mol. Cell Biol. 2010, 11:103-112.
32. Rozengurt E., Rey O., Waldron R.T. Protein kinase D signaling. J.Biol. Chem. 2005, 280:13205-13208.
33. Sahai E., Marshall C.J. ROCK and Dia have opposing effects on adherens junctions downstream of Rho. Nat. Cell Biol. 2002, 4:408-415.
34. Seimetz D., Lindhofer H., Bokemeyer C. Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy. Cancer Treat. Rev. 2010, 36:458-467.
35. Singh R., Lei P., Andreadis S.T. PKC-delta binds to E-cadherin and mediates EGF-induced cell scattering. Exp. Cell Res. 2009, 315:2899-2913.
36. Slanchev K., Carney T.J., Stemmler M.P., Koschorz B., Amsterdam A., Schwarz H., Hammerschmidt M. The epithelial cell adhesion molecule EpCAM is required for epithelial morphogenesis and integrity during zebrafish epiboly and skin development. PLoS Genet. 2009, 5:e1000563.
37. Steinberg S.F. Distinctive activation mechanisms and functions for protein kinase Cdelta. Biochem. J. 2004, 384:449-459.
38. Trebak M., Begg G.E., Chong J.M., Kanazireva E.V., Herlyn D., Speicher D.W. Oligomeric state of the colon carcinoma-associated glycoprotein GA733-2 (Ep-CAM/EGP40) and its role in GA733-mediated homotypic cell-cell adhesion. J.Biol. Chem. 2001, 276:2299-2309.
39. Tsukahara Y., Tanaka M., Miyajima A. TROP2 expressed in the trunk of the ureteric duct regulates branching morphogenesis during kidney development. PLoS ONE 2011, 6:e28607.
40. Villablanca E.J., Renucci A., Sapède D., Lec V., Soubiran F., Sandoval P.C., Dambly-Chaudière C., Ghysen A., Allende M.L. Control of cell migration in the zebrafish lateral line: implication of the gene "tumour-associated calcium signal transducer," tacstd. Dev. Dyn. 2006, 235:1578-1588.
41. Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 2008, 8:755-768.
42. Wong C., Jin Z.G. Protein kinase C-dependent protein kinase D activation modulates ERK signal pathway and endothelial cell proliferation by vascular endothelial growth factor. J.Biol. Chem. 2005, 280:33262-33269.